Inspire Medical Systems (INSP) Competitors $86.10 -43.85 (-33.74%) Closing price 03:59 PM EasternExtended Trading$86.30 +0.20 (+0.23%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INSP vs. SNN, SOLV, PEN, STVN, GKOS, BLCO, IRTC, SLNO, TMDX, and NVSTShould you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), TransMedics Group (TMDX), and Envista (NVST). These companies are all part of the "medical equipment" industry. Inspire Medical Systems vs. Its Competitors Smith & Nephew SNATS Solventum Penumbra Stevanato Group Glaukos Bausch + Lomb iRhythm Technologies Soleno Therapeutics TransMedics Group Envista Smith & Nephew SNATS (NYSE:SNN) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends. Do institutionals & insiders have more ownership in SNN or INSP? 25.6% of Smith & Nephew SNATS shares are owned by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are owned by institutional investors. 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Comparatively, 2.3% of Inspire Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Do analysts prefer SNN or INSP? Smith & Nephew SNATS presently has a consensus target price of $28.00, suggesting a potential downside of 21.13%. Inspire Medical Systems has a consensus target price of $173.31, suggesting a potential upside of 101.29%. Given Inspire Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe Inspire Medical Systems is more favorable than Smith & Nephew SNATS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Smith & Nephew SNATS 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Inspire Medical Systems 0 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.54 Which has more volatility & risk, SNN or INSP? Smith & Nephew SNATS has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500. Which has stronger earnings & valuation, SNN or INSP? Smith & Nephew SNATS has higher revenue and earnings than Inspire Medical Systems. Smith & Nephew SNATS is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmith & Nephew SNATS$5.81B2.68$412M$2.1616.44Inspire Medical Systems$802.80M3.16$53.51M$2.1739.68 Does the media favor SNN or INSP? In the previous week, Inspire Medical Systems had 34 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 37 mentions for Inspire Medical Systems and 3 mentions for Smith & Nephew SNATS. Smith & Nephew SNATS's average media sentiment score of 1.41 beat Inspire Medical Systems' score of 0.54 indicating that Smith & Nephew SNATS is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Smith & Nephew SNATS 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inspire Medical Systems 13 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Is SNN or INSP more profitable? Inspire Medical Systems has a net margin of 6.17% compared to Smith & Nephew SNATS's net margin of 0.00%. Inspire Medical Systems' return on equity of 10.39% beat Smith & Nephew SNATS's return on equity.Company Net Margins Return on Equity Return on Assets Smith & Nephew SNATSN/A N/A N/A Inspire Medical Systems 6.17%10.39%9.00% SummaryInspire Medical Systems beats Smith & Nephew SNATS on 13 of the 16 factors compared between the two stocks. Get Inspire Medical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INSP vs. The Competition Export to ExcelMetricInspire Medical SystemsMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$3.83B$2.02B$5.55B$20.61BDividend YieldN/AN/A4.73%3.69%P/E Ratio56.5034.4228.9629.41Price / Sales3.1649.41376.3874.37Price / Cash76.0654.1424.4817.52Price / Book3.749.228.654.62Net Income$53.51M-$63.67M$3.25B$995.90M7 Day Performance-33.66%-3.87%0.45%-0.85%1 Month Performance-32.94%7.96%8.27%0.39%1 Year Performance-40.83%21.50%30.29%16.86% Inspire Medical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INSPInspire Medical Systems4.6393 of 5 stars$86.10-33.7%$173.31+101.3%-12.6%$3.83B$802.80M56.501,246Trending NewsEarnings ReportAnalyst ForecastGap DownHigh Trading VolumeSNNSmith & Nephew SNATS3.0935 of 5 stars$31.19-1.5%$28.00-10.2%+1.1%$13.66B$5.81B14.4417,349News CoveragePositive NewsGap UpSOLVSolventum1.3761 of 5 stars$73.80-1.3%$84.38+14.3%+27.8%$12.77B$8.31B34.1722,000News CoveragePositive NewsUpcoming EarningsPENPenumbra4.863 of 5 stars$229.90-1.4%$305.07+32.7%+37.1%$8.90B$1.19B216.894,500Earnings ReportAnalyst DowngradeSTVNStevanato Group2.4189 of 5 stars€25.77-2.8%N/A+33.2%€7.80B€1.19B50.535,521News CoverageGKOSGlaukos3.992 of 5 stars$94.80+0.5%$134.67+42.1%-24.6%$5.42B$383.48M-40.00780Earnings ReportBLCOBausch + Lomb2.0536 of 5 stars$14.47+1.0%$15.45+6.8%-15.7%$5.12B$4.79B-14.0513,500Earnings ReportIRTCiRhythm Technologies1.8294 of 5 stars$137.11+2.2%$137.30+0.1%+123.3%$4.38B$618.59M-43.672,000Earnings ReportInsider TradeSLNOSoleno Therapeutics4.2148 of 5 stars$85.25-1.4%$108.70+27.5%+72.6%$4.30BN/A-18.4530Positive NewsUpcoming EarningsTMDXTransMedics Group2.6393 of 5 stars$105.24-2.7%$129.88+23.4%-14.4%$3.56B$441.54M77.38210News CoverageEarnings ReportAnalyst UpgradeNVSTEnvista3.5783 of 5 stars$20.73-0.3%$20.23-2.4%+22.9%$3.51B$2.51B-3.1712,300Trending NewsEarnings ReportAnalyst UpgradeAnalyst Revision Related Companies and Tools Related Companies Smith & Nephew SNATS Alternatives Solventum Alternatives Penumbra Alternatives Stevanato Group Alternatives Glaukos Alternatives Bausch + Lomb Alternatives iRhythm Technologies Alternatives Soleno Therapeutics Alternatives TransMedics Group Alternatives Envista Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:INSP) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inspire Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
